Even the WSJ wonders: why don’t the FDA, or AIFA, use Ivermectin against Covid-19?
The issue is now so evident that even some mainstream media are starting to get it: why the FDA, and we add AIFA, do not authorize the use of Ivermectin, or Ivermectin, even as a therapeutic tool for covid.
This time it was Henderson and Hooper who asked the question in the Wall Street Journal , a source cited as the bible by our media, but only when it suits them. The two editors ask themselves this question: Why is the FDA attacking a safe and effective drug?
The authors note that the drug has been considered approved and safe for some time, so much so that the manufacturer, Mercks, has donated two billion (we note, billions), of doses to various African countries for the fight against parasite disease. If it has been used en masse in Africa, why can't it be used for Covid? The inventor of his precursor, Satoshi Omura, won the Nobel Prize for this discovery in 2015: if the therapy had ever been considered dangerous they would not have given him this award. Ivermectin fights 21 viruses, including SARS-CoV-2, the cause of Covid-19. A single dose reduced the viral load of SARS-CoV-2 in cells by 99.8% in 24 hours and by 99.98% in 48 hours, according to a June 2020 study published in the journal Antiviral Research . Evidently this magazine is not read by the FDA and even less by the AIFA. In addition to this, there are 70 studies that indicate its effectiveness: all random and unverified episodes? The authors cite another study: Of 115 covid-19 patients who used Ivermectin therapy, none developed lung complications, compared with 11.4% in the control group who, however, followed the FDA's ban on use (and of AIFA). Not only that: out of the four billion doses administered since 1998, there have been only 28 cases of serious neurological adverse events , according to an article published this year in the American Journal of Therapeutics. The same study found that ivermectin was used safely in pregnant women, children and babies. Hence it is a safe and proven medicine.
The authors wonder why an effective treatment is mistreated and ignored, even threatening the doctors who recommend it, a question we too share. What does AIFA do, and how will the government behave in the face of the possibility of a new lockdown? Will it pretend nothing has happened, or will it open up to alternative solutions?
Thanks to our Telegram channel you can stay updated on the publication of new articles of Economic Scenarios.
The article Even the WSJ wonders: why don't the FDA, or AIFA, use Ivermectin against Covid-19? comes from ScenariEconomici.it .
This is a machine translation of a post published on Scenari Economici at the URL https://scenarieconomici.it/perfino-il-wsj-se-lo-chiede-perche-la-fda-o-laifa-non-usano-livermectin-contro-il-covid-19/ on Wed, 04 Aug 2021 19:33:43 +0000.